1)Todokoro D, Kamei S, Goto H et al:Acute retinal necrosis following herpes simplex encephalitis:a nationwide survey in Japan. Jpn J Ophthalmol 63:304-309, 2019
2)森地陽子・臼井嘉彦・奥貫陽子・他:発症から3年および21年後に僚眼に再発した急性網膜壊死の1例.あたらしい眼科28:1769-1772,2011
3)塚本浩介・上本理世・伊藤沙織・他:急性網膜壊死の臨床像.臨眼76:1427-1433,2022
4)Kaplan HJ, Streilein JW:Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J Immunol 118:809-814, 1977
5)毛塚剛司:水痘帯状疱疹ウイルスによる眼炎症と免疫特異性.日眼会誌108:649-653,2004
6)Wenkel H, Streilein JW, Young MJ:Systemic immune deviation in the brain that dose not depend on the integrity of the blood-brain barrier. J Immunol 164:5125-5131, 2000
7)袖山博健・戸所大輔・山田教弘・他:急性網膜壊死における原因ウイルスと臨床経過.臨眼68:947-952,2014
8)Teich SA, Cheung TW, Friedman AH:Systemic antiviral drugs used in ophthalmology. Surv Ophthalmol 37:19-53, 1992
9)Kishore K, Jain S, Zarbin MA:Intravitreal ganciclovir and dexamethasone as adjunctive therapy in the management of acute retinal necrosis caused by varicella zoster virus. Ophthalmic Surg Lasers Imaging 8:42, 2011
10)Patel P, Ahmed E, Subramanian ML:Intravitreal foscarnet therapy for acyclovir-resistant acute retinal necrosis after herpes simplex encephalitis. Ophthalmic Surg Lasers Imaging 9:1-3, 2010
11)Wong R, Pavesio CE, Laidlaw DA et al:Acute retinal necrosis:the effects of intravitreal foscarnet and virus type on outcome. Ophthalmology 117:556-560, 2010
12)「単純ヘルペス脳炎診療ガイドライン」作成委員会(編):単純ヘルペス脳炎診療ガイドライン.2017.南江堂,東京,2017
13)Nagafuchi S, Moriyama K, Takamatsu Y et al:Treatment of disseminated herpes zoster in six severely immunocompromised patients:acyclovir and vidarabine. Jpn J Med 28:100-104, 1989
14)白木公康・奥田智子・吉田与志博:アシクロビルとビダラビン処理による薬剤耐性単純ヘルペスウイルス出現の比較.医薬ジャーナル45:119-124,2009